Measurements of Sexual Steroids' Concentrations in Prostatic Tissue
NCT ID: NCT04256161
Last Updated: 2021-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
24 participants
OBSERVATIONAL
2020-06-26
2021-07-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In order to study the in-vivo intra-prostatic concentrations of sex steroid, it is necessary to validate a measurement technique performed on samples obtained by a biopsy needle used in standard care for prostate biopsy punctures allowing the diagnosis and follow-up of prostate cancer.
The aim of this project is to validate this measurement technique carried out on samples obtained by the biopsy needle and to define the optimal number of carrots obtained by biopsy offering dosage results comparable to the punch.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Castration-resistant Prostate Cancer and Intra-prostatic Hormonal Status
NCT03014973
Prostatic Cancer Versus Androgen Deficiency
NCT02235142
Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole
NCT01275651
Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study
NCT00342433
Liquid Biopsy-based Detection of Resistance to Targeted Therapy in Prostate Cancer Patients
NCT03601143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With a bladder cancer
* Should be operated by total cystoprostatectomy at Foch Hospital
* Affiliated to a health insurance scheme
* Having expressed the non-opposition for the participation to the study
Exclusion Criteria
* Patient who does not understand French
* Patient deprived of liberty or under guardianship
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hopital Foch
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yann NEUZILLET, PhD
Role: PRINCIPAL_INVESTIGATOR
Hopital Foch, Suresnes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Foch
Suresnes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018_0049
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.